XML 177 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
12 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company measures certain assets and liabilities at fair value on a recurring basis. The following tables provide details regarding the classification of these assets and liabilities within the fair value hierarchy as of the dates presented:
Financial Instruments of the Company
As of March 31, 2023
Level ILevel IILevel IIITotal
Liabilities
Contingent consideration obligations
$— $— $36,745 $36,745 
Total liabilities$— $— $36,745 $36,745 
As of March 31, 2022
Level ILevel IILevel IIITotal
Liabilities
Contingent consideration obligations
$— $— $28,025 $28,025 
Total liabilities$— $— $28,025 $28,025 
For the liabilities presented in the tables above, there were no changes in fair value hierarchy levels during the years ended March 31, 2023 and 2022.
The changes in the fair value of Level III financial instruments of the Company are set forth below:
Year Ended March 31,
Contingent consideration obligations20232022
Balance, beginning of year:$28,025 $1,541 
Additions
— 17,769 
Change in fair value
9,361 9,600 
Settlements
(641)(885)
Balance, end of year:$36,745 $28,025 
Changes in unrealized losses included in earnings related to financial liabilities still held at the reporting date
$9,361 $9,600 
Contingent Consideration
In connection with the Greenspring acquisition, the Company recorded a contingent consideration liability of $17.8 million during the three months ended September 30, 2021. See note 15 for more information.
The fair value of the contingent consideration liabilities are based on a discounted cash flow analysis using a probability-weighted average estimate of certain performance targets, including revenue levels. The assumptions used in the analysis are inherently subjective; therefore, the ultimate amount of the contingent consideration liability may differ materially from the current estimate. The significant unobservable inputs required to value the contingent consideration liabilities primarily relate to the future expected revenues and the discount rates applied to the expected future revenues and payments of obligations, which ranged from 8% to 10% as of March 31, 2023. The contingent consideration liabilities are included in accounts payable, accrued expenses and other liabilities in the consolidated balance sheets. Changes in the fair value of the liabilities are included in general, administrative and other expenses in the consolidated statements of income. In February 2022, the Company amended the contingent consideration arrangement in respect of the Greenspring acquisition whereby a portion of the contingent consideration liability otherwise payable to the sellers will be used to fund compensation arrangements with certain employees of the Company, which will be payable following the end of the earn-out period. As a result, the contingent consideration liability is recorded net of the fair value of amounts payable to certain employees.
Financial Instruments of Consolidated Funds
As of March 31, 2023
Level ILevel IILevel IIITotal
Assets
Partnership and LLC interests
$— $— $6,901 $6,901 
Total assets$— $— $6,901 $6,901 
Investment Funds
The Company generally values its investment funds, which are organized as partnership and LLC interests, using the NAV per share equivalent calculated by the investment manager as a practical expedient in determining an independent fair value. The Company does not categorize within the fair value hierarchy investments where fair value is measured using the net asset value per share practical expedient. As of March 31, 2023, investments with a combined fair value of $23.7 million are excluded from presentation in the fair value hierarchy as the fair value of these investments were measured at net asset value. As of March 31, 2023, investments with a combined fair value of $6.9 million were classified as level III investments that were purchased during fiscal 2023. There were no unrealized gains or losses related to these investments as of March 31, 2023. The significant unobservable input used to value these investments are the discounts to recent transaction prices. For these investments, there were no changes in fair value hierarchy levels during the year ended March 31, 2023. There were no financial instruments held by Consolidated Funds as of March 31, 2022.